On December 19, 2019 Johnson & Johnson (NYSE: JNJ) reported that it will participate in the 38th Annual JP Morgan Health Care Conference on Monday, January 13, at the Westin St. Francis in San Francisco (Press release, Johnson & Johnson, DEC 19, 2019, View Source;johnson-to-participate-in-38th-annual-jp-morgan-health-care-conference-300977772.html [SID1234552537]). Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices and Jennifer Taubert, Executive Vice President, Worldwide Chairman, Pharmaceuticals will represent the Company in a session scheduled at 2:30 p.m. (Pacific Time)/5:30 p.m. (Eastern Time). A subsequent Question & Answer session is scheduled for 3:00 p.m. (Pacific Time)/6:00 p.m. (Eastern Time).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.